ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Bio View (BIOV.TA)
Bio View stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Tel Aviv Stock Exchange · Israel
₪53.48▲ +5.17%
Prices as of Oct 26, 2026 · ILS
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bio View in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bio View
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Bio View a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₪49.65 and ₪57.42; in 9 out of 10, between ₪43.65 and ₪65.32. Estimated annual volatility is 35%.
Key numbers
- Market cap
- ₪877M
- Market cap (USD)
- $283M
- P/E ratio
- 28.0
- Operating margin
- -21.6%
- Net margin
- -63.3%
- Beta
- 0.00
What this means
ATLAS does not publish a fair value for BIOV.TA right now, but it does show its odds of rising: close to a coin flip.
On the business: net margin is 63.3%; it trades at 28.0 times earnings.
Its beta is 0.00: it tends to move less than the market.
About the company
Bio View Ltd. is a company specializing in the development, manufacture, and marketing of advanced imaging and analysis solutions for cancer detection and monitoring.
Want to see everything about Bio View?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Bio View do?
Bio View Ltd. is a company specializing in the development, manufacture, and marketing of advanced imaging and analysis solutions for cancer detection and monitoring.
What is the chance BIOV.TA goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, BIOV.TA ends the month between ₪49.65 and ₪57.42.
How big is Bio View and what is its P/E ratio?
Bio View's market capitalization is ₪877M. Its price-to-earnings (P/E) ratio is 28.0: you pay ₪28.0 for each ₪1.00 of yearly earnings.
How volatile is BIOV.TA?
ATLAS estimates annual volatility at 35%. In a typical month, half of the outcomes end between ₪49.65 and ₪57.42.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer